Abstract
BackgroundSmall cell lung cancer (SCLC) accounts for 15% of lung cancers, and the primary treatment of this malignancy is chemotherapy and radiotherapy. Delta-like 3 (DLL3) is an attractive target for...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have